Investor
TCGX
2$4.4bn$2.2bn0
Startups backed by TCGX that were acquired: 2 exits so far, with the buyer, the price where disclosed and every source.
Photo: Quintin Soloviev / Wikimedia Commons, CC BY 4.0Johnson & Johnson to buy eye-drug startup Ollin Biosciences for $2.2 billion upfront
Founded in 2023, Ollin could fetch up to about $3.3 billion with milestones, while Blackstone has agreed to pay $750 million toward the Phase 3 trials of its lead drug.
$2.2bn$430mSeries BCorporate
